3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, Large-Cell, Anaplastic
3
Immunoblastic Lymphadenopathy
3
Esophageal Neoplasms
3
Burkitt Lymphoma
3
Adenocarcinoma Of Esophagus
3
Sarcoma
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Lymphoma, Extranodal NK-T-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Triple Negative Breast Neoplasms
1
Thrombocytopenia
1
Testicular Neoplasms
1
Testicular Germ Cell Tumor
1
Teratoma
1
Stomach Neoplasms
1
Spinal Cord Neoplasms
1
Sezary Syndrome
1
Rhabdoid Tumor
1
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Interventions
Cytarabine
23
fludarabine phosphate
9
Daunorubicin
9
Mitoxantrone
8
Busulfan
8
Peripheral Blood Stem Cell Transplantation
6
Methotrexate
6
Idarubicin
6
Gemtuzumab
6
Etoposide
6
Whole-Body Irradiation
5
Filgrastim
5
Cyclophosphamide
5
Clofarabine
5
tipifarnib
4
alvocidib
4
Vorinostat
4
Tacrolimus
4
Cyclosporine
4
Azacitidine
4
Antilymphocyte Serum
4
sargramostim
3
Observation
3
Mycophenolic Acid
3
Flow Cytometry
3
Decitabine
3
Cytogenetic Analysis
3
Bortezomib
3
fludarabine
2
aldesleukin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Erythroblastic, Acute
×
Microarray Analysis
×
Clear all
No trials found.